Featured Research

from universities, journals, and other organizations

New Study Sheds Light On Higher Adherence To HIV Drugs In Africa Than In North America

Date:
January 26, 2009
Source:
Public Library of Science
Summary:
Levels of near-perfect adherence to life saving anti-retroviral drugs among African HIV patients should be understood as a means of preserving key social relationships, says a new study.

Levels of near-perfect adherence to life saving antiretroviral drugs among African HIV patients should be understood as a means of preserving key social relationships, says a new study.

In Sub-Saharan Africa, adherence to these anti-HIV drugs improves patients' health, which is also a strong predictor of adherence success in developed countries. But for individuals living in extreme poverty, adhering to antiretroviral medicine regimens also helps them protect the relationships they rely upon to survive.

Norma Ware from Harvard University, Boston, USA and colleagues interviewed 252 patients and caregivers in Nigeria, Tanzania and Uganda, and identified several strategies used by patients to overcome economic obstacles to ART adherence. Strategies aimed at prioritizing adherence included borrowing and begging for funds to pay for travel to clinics, making difficult choices that reallocated available resources in favor of treatment, and "doing without."

Dr. Ware and colleagues report that individuals' prioritizing of ART adherence reflected the importance of relationships as a resource for managing economic hardship: caregivers and supporters expected patients to adhere to ART, and they made their expectations known. This created a responsibility among patients to adhere. Patients, in turn, adhered to their treatment to promote good will from their caregivers, thereby ensuring help will be available when future needs arise, say the authors.

That HIV patients in Africa achieve close to 90% adherence rates—far exceeding those achieved in North America—is remarkable given the "formidable obstacles in the poorest regions of the world," say the authors. This "dispels early scale-up concerns that adherence would be inadequate in settings of extreme poverty." The authors conclude that adherence success is best explained as a means of fulfilling social responsibilities and thus preserving social capital in economic and cultural settings where good relationships are necessary for survival.

In an expert commentary on the study, Agnes Binagwaho and Niloo Ratnayake, who were not involved in the study, discuss the importance of social capital in African societies compared to more developed countries, stating that "people in the US tend to be more individualistic and therefore less focused upon and connected to the group as a whole." The challenge for African will be to "maintain social capital while improving economic development, which can bring a more individualistic way of life."


Story Source:

The above story is based on materials provided by Public Library of Science. Note: Materials may be edited for content and length.


Journal Reference:

  1. Ware et al. Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study. PLoS Medicine, 2009; 6 (1): e11 DOI: 10.1371/journal.pmed.1000011

Cite This Page:

Public Library of Science. "New Study Sheds Light On Higher Adherence To HIV Drugs In Africa Than In North America." ScienceDaily. ScienceDaily, 26 January 2009. <www.sciencedaily.com/releases/2009/01/090126203159.htm>.
Public Library of Science. (2009, January 26). New Study Sheds Light On Higher Adherence To HIV Drugs In Africa Than In North America. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2009/01/090126203159.htm
Public Library of Science. "New Study Sheds Light On Higher Adherence To HIV Drugs In Africa Than In North America." ScienceDaily. www.sciencedaily.com/releases/2009/01/090126203159.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins